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Abstract.  We have used an in vitro assay that recon- 
stitutes transport from the ER to the Golgi complex in 
yeast to identify a functional vesicular intermediate in 
transit to the Golgi apparatus.  Permeabilized yeast 
cells, which serve as the donor in this assay, release a 
homogeneous population of vesicles that are biochemi- 
cally distinct from the donor ER fraction. The isolated 
vesicles, containing a post-ER/pre-Golgi form of the 
marker protein pro-a-factor, were able to bind to and 
fuse with exogenously added Golgi membranes. The 
ability to isolate fusion competent vesicles provides 
direct evidence that ER to Golgi membrane transport 
is mediated by a discrete population of vesicular 
carriers. 
C 
ARRIER vesicles have been proposed  to mediate the 
transport  of macromolecules  from the rough endo- 
plasmic  reticulum  (ER)  to the cis-Golgi complex 
(Jamieson and Palade, 1967; Palade, 1975). However, direct 
evidence for the existence of this vesicular compartment has 
not been obtained.  Various approaches  have been used to 
identify and isolate a potential intermediate in transit to the 
Golgi complex.  Electron microscopic analysis and physio- 
logical  studies  have  shown that low temperatures  inhibit 
transport between the ER and Golgi apparatus in mammalian 
cells (Saraste  and Kuismanen,  1984, Saraste et al.,  1986; 
Tartakoff, 1986). At 15°C, the Golgi complex vesicularizes 
and proteins  in transit  to this compartment  accumulate in 
pre-Golgi vacuoles. To enrich for vesicles that are likely to 
mediate transport at this stage of the pathway, methods such 
as the fractionation of membranes which have been labeled 
kinetically in vivo (Lodish et al., 1987) and preparative free- 
flow electrophoresis" (Paulik  et al.,  1988) have also been 
used. Further studies or other approaches will be needed to 
obtain more highly enriched vesicle fractions. 
Coated vesicles involved in intra-Golgi membrane traffic 
(Malhotra et al., 1989) and secretory vesicles that transport 
proteins  from the trans-Golgi network  (de Curtis  and Si- 
mons, 1989) can be formed in vitro. This approach has per- 
mitted the identification and extensive purification of inter- 
mediate compartments  that act at two distinct steps of the 
pathway. A genetic approach has also been employed in the 
yeast Saccharomyces cerevisiae to isolate post-Golgi secre- 
tory vesicles.  Temperature-sensitive  mutants defective for 
transport at this stage of  the pathway accumulate vesicles that 
fail to deliver their contents to the plasma membrane (No- 
vick et al.,  1981). The yeast post-Golgi secretory mutants 
have made it feasible to trap an intermediate that is normally 
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present in low amounts in the cell,  facilitating the purifica- 
tion of secretory vesicles (Walworth and Novick, 1987; Hol- 
comb et al., 1987). Although these approaches have led to 
the isolation of  highly purified vesicle fractions, these vesic- 
ular compartments were not shown to be functional for trans- 
port and as such could not be used to address the mechanism 
of vesicle consumption. 
In an effort to characterize the mechanism by which pro- 
teins are transported  from the ER to the Golgi complex we 
have reconstituted  these  events in vitro  (Ruohola  et al., 
1988). A radiolabeled precursor of the secreted pheromone 
or-factor is used as a marker protein in our assay. This 19-kD 
marker protein is translated in vitro with a yeast lysate and 
translocated  into a donor compartment  (the ER)  retained 
within permeabilized yeast cells (PYC)) After translocation 
and the addition of N-linked oligosaccharides, pro-u-factor 
(26 kD) is transported  to functional acceptor  Golgi mem- 
branes,  added exogenously to the cells, where it is further 
glycosylated to form a high molecular mass species. In this 
report  we describe the use of this in vitro transport  assay 
to isolated vesicles which have budded from the ER and are 
competent to fuse with the Golgi complex. The isolation of 
fusion competent vesicles provides direct evidence that car- 
rier vesicles mediate transport at this stage of the pathway. 
This approach has enabled us to address the requirements for 
vesicle formation and utilization. 
Materials and Methods 
Growth Conditions and Strains 
The yeast strains used in this study were: wild type, SFNY26-tA (MAT a, 
his4-619)  and JRY  1239  (MAT a,  HMG1,  HMG2,  ura3-52,  his3A200, 
ade2-101,  lys2-801,  met  +  pJR59 (HMG1  URA3 2it; YEp24 derivative). 
1. Abbreviation used in this paper:  PYC, permeabilized yeast cells. 
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tions were grown overnight at 25°C in YPD medium (1% yeast extract, 2% 
Baetopeptone, and 2% glucose) to early log phase (ODs99 =  1.5-4). JRY 
1239  was grown in Wickerham's minimal medium (1946)  supplemented 
with histidine, adenine, lysine,  and methionine to an OD599  =  1.0. To 
change growth medium, cells were harvested in a clinical centrifuge at room 
temperature and then resuspended in new medium. Cell densities were mea- 
sured in a 1-cm cuvette in a spectrophotometer  (ultrospec plus; LKB Instru- 
ments, Gaithersburg, MD). 
One-step In Vitro Transport Assay 
All reagents used were obtained from Sigma Chemical Co., St. Louis, MO 
unless otherwise indicated. Prepro-a-factor  was translated in vitro in a yeast 
translation lysate according to the protocol of Hansen et al. (1986) with mi- 
nor modifications. Permeabilized yeast cells, donor cells, and $3 fraction 
were prepared as described before (Ruohola et al.,  1988).  The cytosolic 
fraction (also referred to as high speed supernatant or HSS) and the crude 
membrane fraction containing the functional acceptor compartment (also 
referred to as high speed pellet or HSP) were prepared from an $3 fraction 
centrifuged at 120,000 g for 1 h (36,000  rpm in a rotor; SW50;  Beckman 
Instruments, Inc., Paio Alto, CA). Regenerated spberoplasts, used to pre- 
pare the components required for the assay,  were used immediately or 
stored overnight on ice as a packed pellet. Protein was measured by the 
method of Bradford (1976)  using ovalbumin as a protein standard. 
The transport assay was usually performed in a total volume of 55-82 
#1:25 t~l of donor PYC (60 #g of protein), 26-50 t~l of an $3 fraction (1.0 
mg of protein), 26-50 t~l of a cytosolic fraction (0.7-0.8  mg of protein), 
26-50 ~1 of a crude membrane fraction (0.2-0.4 rng of protein), 0.9 mM 
GDP-mannose, and an ATP-regenerating system (1 mM ATE 0.1 mM GTP, 
20 mM creatine phosphate, 0.2 mg/ml creatine phosphate kinase). Apyrase 
was used as described before (Ruohola et al., 1988).  All components were 
incubated for varying amounts of time at 20°C. At the end of the assay, the 
donor PYC were centrifuged at room temperature for 23 s in a microfuge 
(Fisher Scientific Co., Pittsburgh, PA). The supernatant and pellet fractions 
were incubated with trypsin (0.47 mg/ml) for 20 min on ice. Trypsin inhibi- 
tor was added to each sample (1.88 mg/ml), the incubation was continued 
for 5 rain, and the mix was heated at 100*C in the presence of 1% SDS. 
Forms of pro-a-factor were precipitated with 2 #1 of anti-a-factor anti- 
body or by binding to Con A-Sepharose. To precipitate pro-a-factor with 
antibody, samples were diluted with 1 ml of PBS-Triton (12.5 mM sodium 
phosphate, 0.2 M NaCI, 2 % Triton X-100) containing I x  protease inhibitor 
cocktail (Waters and Blobel, 1986) and incubated for 2 h at room tempera- 
ture or overnight on ice in the presence of 2/zl of anti-a-factor antibody. 
The antigen-antibody complexes were precipitated by binding to protein 
A-Sepharose as described before (Newman and Ferro-Novick, 1987).  The 
beads were washed two times with 1 ml of urea wash buffer (2 M urea, 200 
mM NaC1,  1% Triton X-100,  100 mM Tris, pH 7.6) and two times with 1 
ml of 1%/~-mereaptoethanol. Pro-a-factor was sohibilized from the beads 
in 70 ttl of sample buffer.  When Con A-Sepharose was used, the SDS- 
treated sample was diluted with 1 ml of high salt wash (500 mM NaC1,  1% 
Triton X-100, 20 mM Tris, pH 7.5) and then incubated for 2 h at room tem- 
perature with 90 td of a 20% (vol/vol) solution of Con A-Sepharose. The 
beads were washed as described before (Bacon et al., 1989) except that each 
wash buffer was used only once. Forms of pro-a-factor were solubilized 
from the beads by heating in 70 ttl of sample buffer.  Solubilized samples 
were always analyzed in two ways: by electrophoresis  in a 12.5 % SDS-poly- 
acrylamide slab gel and by liquid scintillation counting using a scintillation 
counter (LS 5000TD;  Beckman Instruments, Inc.). 
Anti-outer chain antibody was used to quantitate conversion of the 26- 
kD species to the high molecular mass form of pro-c~-factor. This antibody 
was raised by injecting heat-killed wild-type yeast cells (X2180-LA  and 
SFNY26-tA) into New Zealand white rabbits as described before (Ballou, 
1970).  Characterization of this antibody indicated that it specifically recog- 
nized the high molecular mass Goigi form of pro-a-factor (see Fig.  1 A) 
and not the 26-kD species. 
To precipitate the high molecular mass Golgi form of pro-a-factor, 20 
/tl of the sample treated with either Con A-Sepharose or anti-a-factor anti- 
body, was diluted (1:10) with PBS-Triton and incubated for 2 h at room tem- 
perature in the presence of 6 ttl of anti-outer chain antibody. At the end of 
this incubation,  samples were incubated with protein A-Sephayose and 
washed as before. Pro-a-factor was sohibilized from the beads with 70/~1 
of sample buffer. The cpm reported in all figures were based on the counts 
obtained from 20 tzl of a sohibilized sample. The zero time point (which 
contained 10% or less of the total counts) was subtracted from all samples 
analyzed. 
Two-step In Vitro Transport Assay 
When the assay was performed in two steps, vesicles were released from 
cells during a 30- or 60-min incubation containing donor PYC, cytosol or 
a crude membrane fraction, and an ATP-regenerating system at 20°C. The 
supernatant fraction, containing vesicles, was separated from the donor 
compartment by centrifugation (23 s) in a microfuge (Fisher Scientific Co.) 
and was subsequently incubated with a crude membrane fraction during a 
second incubation (60-90 min) at 20°C. Samples were then processed as 
described above. 
Gel Filtration of Vesicles  Released from Donor Cells 
A total of 10-11 assays (donor PYC, cytosol, and an ATP-regenerating sys- 
tem) were performed simultaneously at 20°C for 60 min. Afterwards, the 
donor cells were pelleted, and the vesicles released into the soluble fraction 
were separated from cytosol on a 13 ml Sephacryl S-300 column (Pharma- 
cia LKB Biotechnology, Inc., Piscataway,  NJ) that was equilibrated with 
transport buffer (115 mM potassium acetate, 2.5 mM magnesium chloride, 
0.2 M  sorbitol,  lx  protease inhibitor [described by Waters and Blobel, 
1986],  and 1/40 vol of 1 M  Hepes, pH 7.2).  The column was calibrated 
using the following markers: blue dextran (2,000,000 D); BSA (66 kD); 
cytochrome c (12.4 kD); p-nitrophanol (139 D). Blue dextran eluted in the 
void volume (fraction 10), while BSA and cytochrome c were in fraction 
17 and p-nitrophenol was in fractions 34 and 35. The vesicles eluted in the 
void volume (fractions 10 and 11) and were cleanly separated from the solu- 
ble markers.  To approximate the ratio of vesicles to acceptor normally 
maintained in the reaction, the vesicle fractions were concentrated (1.25 
times greater than the original volume) by centrifugation in a concentrator 
(centricon-10; Amicon Corp., Danvers, MA) for 1 h at 5,000 g. Approxi- 
mately 40-50%  of the vesicles were recovered after concentration. 
Results 
Vesicles Containing the 26 kD Pro-or-Factor Precursor 
Are Released  from Donor PYC 
When donor PYC  are incubated with cytosol, ATP,  and a 
crude membrane fraction that contains the acceptor com- 
partment, the 26-kD pro-t~-factor precursor exits the ER and 
is transported to the Golgi apparatus where it is terminally 
glycosylated. During this incubation, a fraction of the 26-kD 
species is  released from the donor cells (Ruohola et al., 
1988). If the pro-u-factor precursor that is released from the 
cells is contained within vesicles that are derived from the 
ER, it should pellet during high speed centrifugation and be 
resistant to digestion by protease. To address these points, 
donor PYC, cytosol, and ATP were incubated and then briefly 
sedimented at 11,000 g. The pro-u-factor remaining in the 
supernatant was subjected to centrifugation at •120,000  g 
for 1 h. Aliquots of the resulting supernatant and pellet were 
treated with or without trypsin and then precipitated with the 
solid phase lectin adsorbant Con A-Sepharose. The data in 
Fig.  1 indicate that most of the Con A-precipitable counts 
were pelletable and resistant to digestion by trypsin in the 
absence of  detergent. The small fraction of Con A-precipita- 
ble counts that remained in the supernatant were largely sen- 
sitive to protease digestion. These findings indicate that the 
majority ofpro-t~-factor released from cells during the trans- 
port reaction is protected by a sealed membrane. 
To determine whether pro-u-factor released from donor 
cells is contained within a homogeneous population of mem- 
branes, the putative transport vesicles were examined using 
sucrose gradients. The appearance of heterogeneous mem- 
brane species containing 26-kD pro-a-factor might suggest 
that the vesicles are contaminated with artifactually vesicu- 
larized ER membranes released from donor cells. 
The vesicles were first analyzed on an equilibrium sucrose 
The Journal  of  Cell  Biology,  Volume 11  l, 1990  46 12oo0] 
8  8oo0 
o~ 
"~  6ooo 
"~  4000 
.~  2000 
Supernatant  Pellet 
Trypsin  +  + 
l~gure L The 26-kD pro-u-fac- 
tor  precursor  released  from 
the  donor PYC  is  contained 
within  a  sealed  membrane 
compartment.  Donor  PYC 
were  incubated  with  cytosol 
and ATP at 20°C. Afterwards, 
the cells were centrifuged in a 
microfuge (23 s) and the pro- 
a-factor remaining in the su- 
pernatant was recentrifuged at 
120,000 g for 1 h. Pro-or-fac- 
tor in the supernatant  and in 
the pellet was treated with or 
without trypsin as described  in Materials  and Methods and then 
precipitated  with Con A-Sepharose. 
A 
g  g 
c_ 
£ 
50 
10 
8(X)" 
400' 
200" 
0  --  ,  .... 
0  10 
Fractions 
e~  z 
.e 
3000 
2000 
10CO" 
1 
10 
Fractions 
• 0.2 
÷ 
-0.1 
# 
0.0 
20 
800 
600 
'400 
• 200 
0 
20 
.o 
v 
Figure 2. Sedimentation analysis of the vesicles released from do- 
nor PYC. (A) A total of 11 (55-/~1 each) transport reactions (donor 
PYC, cytosol, and an ATP-regenerating system) were performed 
simultaneously at 20°C for 20 min. At the end of the transport as- 
say, the PYC were pelleted and the supematant (350 #1) was resus- 
pended  in  1.2 ml of 60%  (wt/wt)  sucrose buffered with  10 mM 
Hepes,  pH 7.2. The sample was placed at the bottom of a 5-ml 
ultraclear centrifuge tube (Beckman Instruments, Inc.) and overlaid 
with the following solutions of sucrose:  1 ml 40%  (wt/wt),  1 ml 
30% (wt/w0, and 1 m120% (wt/wt). The gradient was centrifuged 
in a SW50.1 rotor for 15 h at 120,000 g and then fractionated from 
the top (fraction volume '~300 #1). A portion of each fraction (50 
•1)  was treated with trypsin (10 t~g for 20 rain at 0°C) and then with 
trypsin inhibitor  (40 #g for 5 min at 0°C). Samples were heated 
at 100oC in 1% SDS. Pro-a-factor was precipitated from each frac- 
tion with anti-u-factor antibody and quantitated by densitometric 
scanning of autoradiograms.  Protein was measured by the method 
of Bradford  (1976). The density  of sucrose  in each fraction  was 
measured by refractometry. (B) Vesicles were formed with the con- 
ditions described  in A. A portion of the supernatant  (200/~1) was 
layered on top of a 10-50%  (wt/wt) linear 5-ml sucrose gradient 
gradient. The migration of vesicles in this'gradient was as- 
sessed by assaying fractions for trypsin-resistant pro-a-fac- 
tor (26  kD).  Vesicles were resuspended  in 60%  sucrose, 
placed at the bottom of a centrifuge tube, and overlaid with 
sucrose solutions of decreasing concentration:  40,  30,  and 
20%. After a 15-h centrifugation at ,x,120,000 g, the vesicles 
had migrated as a single peak at the same density as 40% 
sucrose (1.1764  g/cm0 (Fig.  2 A). We noted that the vesi- 
cles released from the PYC during the assay are less dense 
than the yeast ER membrane, which pellets in 40% sucrose 
(Ruohola and Ferro-Novick, 1987). When the vesicles were 
subjected to centrifugation (~150,000 g for 140 min) through 
a  10-50%  linear sucrose gradient, they sedimented at 28- 
30% sucrose (Fig. 2 B). Thus, under different gradient and 
centrifugation conditions, the vesicles still migrate as a sin- 
gle population. These findings suggest that only one mem- 
brane  species,  which  contains  the  26-kD  form of pro-a- 
factor, is released from donor cells during the assay. 
Vesicles Containing the 26-kD Precursor Form of 
Pro-t~-Factor Are Intermediates in Transport 
We hypothesized that the 26-kD precursor of pro-a-factor 
may be contained within a vesicular compartment that medi- 
ates transport from the ER to the Golgi complex. Accord- 
ingly, vesicles containing the 26-kD species must be released 
from the permeabilized cells before transport to the Golgi 
complex can occur. To test this proposal, the kinetics of pro- 
a-factor transport were  monitored.  Donor  PYC  were in- 
cubated with cytosol and the acceptor compartment for vari- 
ous times at 20°C. Afterwards, the permeabilized cells were 
removed by centrifugation and the supernatant was assayed 
for both the 26-kD and high molecular mass Golgi species 
by precipitation with  anti-a-factor antibody.  Antibody di- 
rected against outer chain carbohydrate, which is added to 
yeast glycoproteins only in the Golgi complex (Kukuruzin- 
ska et al., 1987), was used in a second immunoprecipitation. 
This antibody precipitates the high molecular mass species, 
but not the 26-kD form of pro-a-factor (see Fig.  3 A). The 
results in Fig. 3 B indicate that the time course of outer chain 
addition to pro-a-factor can be divided into three phases: a 
lag period (~10 min), a  linear phase,  and a plateau phase 
(Fig.  3  B).  Most of the  anti-a-factor precipitable counts 
were released rapidly from the donor PYC before completion 
of the lag in outer chain addition, and release was not depen- 
dent upon the presence of functional acceptor membranes 
(compare Fig. 3, B and C). These findings indicate that the 
26-kD form of pro-a-factor is released from donor PYC be- 
fore the high molecular mass Golgi species is detected. 
We reported in an earlier study (Bacon et al.,  1989) that 
the 26-kD form of pro-a-factor is processed to a 28-kD spe- 
cies before it is converted to the high molecular mass form. 
Conversion to 28-kD pro-a-factor requires the presence of 
the acceptor fraction (Bacon et al.,  1989),  suggesting that 
the 28-kD  species resides  in a  post-ER compartment that 
prepared in 10 mM Hepes, pH 7.2. The gradient was centrifuged 
in a SW50.1 rotor at 40,000 rpm for 140 min and fractionated (frac- 
tion volume ,'~300 #1) from the top. The location of vesicles in each 
fraction was determined as described in A except that Con A-Seph- 
arose was used to precipitate the 26-kD species from each fraction. 
Groesch et al.  Yeast ER to Golgi Transport Vesicles  47 Figure 3. Vesicles  are released from the donor PYC before the high molecular mass Golgi species is detected.  (A) The donor PYC were 
incubated for 90 min at 20°C  in the presence of a supernatant of a yeast lysate centrifuged at 3,000 g  ($3  fraction). At the end of the 
incubation, the cells were pelleted in a microfuge and the supernatant was treated with Con A-Sepharose (lane 1). The Con A-precipitable 
material was then reprecipitated with anti-outer-chain antibody as described in Materials and Methods (lane 2). Anti-outer-chain antibody 
precipitated the highest molecular mass forms of pro-t~-factor and not the 26-kD form. (B) The donor compartment was incubated with 
an $3 fraction for various times at 20°C. At each time point, the donor PYC were pelleted and the supernatant was treated with trypsin 
(0.47  mg/ml) during a 20-min incubation on ice.  Trypsin inhibitor (1.88 mg/ml) was added and after 5 rain the sample was boiled in the 
presence of 1% SDS.  Trypsin-resistant pro-tx-factor that remained in the supernatant was first precipitated with anti-u-factor antibody 
and then reprecipitated with anti-outer-chain antibody. The cpm reported were based on counts obtained from 20/~1 ofa solubilized sample 
that was quantitated by liquid scintillation counting. The findings  shown in B and C were averaged from three experiments. The zero time 
point was subtracted from all samples analyzed; generally this sample contained  10%  or less of the total counts.  Outer-chain addition 
denotes the counts precipitated  with anti-outer-chain antibody and  ot-factor-precipitable counts  indicates the counts precipitated with 
anti-a-factor antibody.  (C) The same as in B except that the donor PYC were incubated with cytosol (no functional acceptor compartment 
present) in the presence of an ATP-regenerating system. 
may be an early subcompartment of the Golgi complex.  A 
time course of this processing event is shown in Fig. 4. Ini- 
tially,  only  26-kD  pro-or-factor  and  partially  glycosylated 
forms of pro-c~-factor (described in Ruohola et al.,  1988) are 
seen outside the cells  (Fig.  4,  lane  1 ).  However,  by 5  min 
(and before completion  of the lag),  the 28-kD  species also 
appears  (Fig.  4,  lane  2).  Thus,  26-kD  pro-a-factor  is  re- 
leased from donor PYC before the appearance of the 28-kD 
form. 
Requirements for Vesicle Formation and Release 
The requirements for ER-derived transport vesicle formation 
were assessed quantitatively by monitoring release of pro-o~- 
factor  from donor-permeabilized  yeast cells.  Pro-c~-factor, 
contained  within  a  sealed  membrane  compartment,  was 
released  from cells  when  the  donor  compartment  was  in- 
cubated with cytosol and ATP at 20°C (Fig.  3  C and Fig. 5, 
lane A).  Vesicle release was dependent upon the concentra- 
tion of cytosol used in the experiment, increasing severalfold 
as the cytosol concentration was raised from 0.05 to 0.8 mg 
protein per reaction.  If the cytosolic fraction was heated to 
95°C  for 15  min before its use in the assay, vesicle release 
was dramatically  reduced  (Fig.  5,  lane B).  Vesicle release 
failed to occur when  the  incubation  was performed on ice 
(Newman,  A.,  M.  Groesch  and  S.  Ferro-Novick,  unpub- 
lished  results).  These  findings  imply  that  proteins  in  the 
cytosol  are  responsible  for forming  and  releasing  vesicles 
from donor-permeabilized  cells in vitro.  ATP was required 
for this event since apyrase, an enzyme that hydrolyzes ATP 
to ADP and P~, blocked this process (Fig.  5, lane C).  There- 
fore, vesicle release from donor-permeabilized cells requires 
Figure 4. The 28-kD form of pro-c~-factor  appears during the first 
10 min of the transport assay. Donor PYC were incubated at 200C 
with cytosol, a crude membrane fraction that contains the acceptor 
compartment, and ATP for the indicated times. At each time point 
the cells were pelleted and the supernatant and pellets were treated 
as described in Materials and Methods. The gel of the supernatant 
is shown. 
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permeabilized cells were incubated for 90 min with cytosol and 
ATP (lane A), with heat-treated cytosol (15 min at 95°C and then 
centrifuged for 1 min in a microfuge [Fisher Scientific Co.]) and 
ATP (lane B), with cytosol and apyrase to deplete ATP (lane C), 
with a crude membrane fraction (lane D), or with cytosol, crude 
membranes, and apyrase (lane E). At the end of  the assay, the donor 
PYC were pelleted and samples were treated as described in Mate- 
rials and Methods. Vesicle release was measured as described be- 
low. The values presented in this figure are representative. The pro- 
tein concentration of cytosol, as determined by the Bradford assay, 
was approximately 0.7-0.75 mg per reaction.  % release =  (Con 
A-precipitable  counts in the supernatant  -  Con A-precipitable 
counts of the zero time point)/(total Con A-precipitable counts in 
the supernatant and pellet). 
Figure 6.  HMG-CoA reduc- 
tase  (HMG1) is  not released 
into the vesicle fraction dur- 
ing the  reaction. Parallel in 
vitro transport assays were per- 
formed using either  radiola- 
beled or unlabeled pro-a-fac- 
tor translocated into the ER of 
donor  PYC  prepared from 
JRY 1239, a strain that over- 
produces HMG1. Donor PYC 
containing  radiolabeled  pro- 
a-factor were incubated with an $3 fraction and ATP and vesicle 
release was measured as described for Fig. 4. The donor PYC trans- 
located with unlabeled pro-a-factor  were incubated with an  $3 
fraction (prepared from SFNY 26-6A) that does not contain detect- 
able amounts of HMG1. The amount of HMG1 released from these 
donor cells was determined by Western blot analysis. The PYC were 
pelleted and the supernatant fraction was centrifuged at 120,000 g 
for 1 h, conditions that efficiently  pellet vesicles. HMG1 was solu- 
bilized from this pellet and from the donor PYC during a 15-min 
incubation at 65-70°C in sample buffer containing protease inhibi- 
tors. Samples were then boiled and subjected to SDS-polyacryl- 
amide gel electrophoresis (7.5%) and  electrophoretically trans- 
ferred onto nitrocellulose. Anti-HMG1 antiserum was used at a 
dilution of 1:1,000 and the nitrocellulose filters were dried and ex- 
posed to Kodak XAR-5 film at -800C. The graph shows the per- 
cent of pro-a-factor  and HMG1 released into the supernatant at 
equivalent times during the parallel assays. No detectable amounts 
of HMG1 were released into the supernatant fraction. 
a donor compartment, ATP, and proteins present in the cy- 
tosol. 
Donor cells also released vesicles when they were assayed 
in the presence of a crude membrane fraction (Fig. 5, lane 
D) and an ATP-regenerating system. These membranes re- 
tained their vesicle-forming activity even after residual con- 
taminating cytosol was removed from this fraction. There- 
fore, proteins required  for this  event can also be supplied 
from a concentrated crude membrane fraction. Preliminary 
findings  suggest that the factors required  for vesicle bud- 
ding may be released  from membranes in a  soluble form 
(Groesch, M.,  and S.  Ferro-Novick, unpublished results). 
One explanation for this observation is that budding factors 
may be peripheral membrane proteins that do not partition 
completely to the cytosol during the fractionation procedure. 
Donor PYC were unable to release vesicles when they were 
incubated with a crude membrane fraction and apyrase in the 
presence (Fig. 5, lane E) or absence of cytosol. In addition, 
there was no vesicle release when the cells were incubated 
with  an  ATP-regenerating  system  in  the  absence  of both 
cytosol and crude membranes (not shown).  This indicates 
that  membranes  residing  in  the  donor  fraction  are  not 
sufficient for efficient  vesicle release.  It is possible that the 
active components on these membranes are released during 
preparation of the permeabilized donor cells.  Alternatively, 
the membranes may not be present in sufficient  quantities to 
support vesicle release. 
An ER Marker Protein Is Not Released  from Donor 
PYC during Vesicle Formation and Release 
The movement of proteins along the secretory pathway is a 
dynamic process.  Resident proteins of the ER must be re- 
tained during membrane flow, while secreted proteins are 
sorted into vesicles destined to exit this organdie. We have 
shown above that pro-a-factor released from the cells is con- 
tained  within a  homogeneous membrane species.  If these 
membranes are transport vesicles, rather than artifactually 
vesicularized  ER,  then  the  yeast  ER  membrane  protein 
HMG-CoA reductase  (Wright et al.,  1988)  should be re- 
tained in donor cells during vesicle formation. To address 
this  question,  parallel  transport assays were performed at 
20°C. Vesicle forming activity was measured in the standard 
assay,  while the distribution of an  isozyme of HMG-CoA 
reductase (HMG1) was assessed from an assay in which un- 
labeled pro-a-factor was translocated into the donor com- 
partment. At the end of the assay, the presence of HMG1 was 
determined in both the supernatant and pellet fractions by 
Western blot analysis. We observed that HMG1 resided in 
the  pelleted  donor PYC  and  no detectable  amounts  were 
released from cells during the assay (Fig.  6).  Titration ex- 
periments demonstrated that 8 % or more of the total HMG1 
released into the supernatant fraction could be detected by 
this method of analysis (not shown). Based on these findings 
we can conclude that 0-8 % of the total HMG1 was released 
from donor  cells,  whereas  47%  of the  pro-u-factor was 
released  from donor cells.  Thus,  pro-a-factor was  sorted 
into vesicles while a resident protein was retained in the do- 
nor fraction. 
Vesicles Are Not Derived  from an Inactive Post-ER 
Compartment Retained in Donor Cells 
To further characterize the vesicles released from the donor 
PYC,  we determined if they could be derived from Golgi 
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3 and 4 vs. lanes 2 and 5). Therefore it appears that endoge- 
nous Golgi membranes defective for transport may reside in 
the PYC. Since the 28-kD species is not observed in vesicles 
released  from the permeabilized cells during  our  normal 
reaction, we can conclude that these vesicles have not fused 
with post-ER membranes within the cells. Furthermore, iso- 
lated vesicles containing 26-kD pro-a-factor are unable to 
process pro-a-factor to the 28-kD species by the addition of 
MnCI~  (not  shown),  supporting  our  conclusion  that  the 
vesicular intermediate is not derived from a post-ER com- 
partment. 
Figure 7. Donor PYC contain the compartment  that converts the 26- 
kD species to the 28-kD form of  pro-c~-factor.  Donor PYC were in- 
cubated with 5 mM manganese chloride in the absence of cytosol 
and  exogenously added membranes for 90 min at 20°C.  After- 
wards,  the  cells  were  centrifuged  and  forms  of  pro-u-factor 
released into the supernatant (lanes 3 and 4) and residing in the pel- 
let (lanes 2 and 5) were examined. The 28-kD species was pro- 
duced only when the assay was performed in the presence of man- 
ganese chloride  (lane 2 vs. lane 1).  The formation of the 28-kD 
species also was observed when apyrase was added to the incuba- 
tion (lane 5). 
The Vesicles Formed In Vitro Are Functionally Active 
for Transport 
The data presented thus far would suggest that the vesicles 
formed in  vitro are  an  intermediate in  transport.  Carrier 
vesicles that mediate transit between the ER and Golgi should 
bind to and fuse with acceptor Golgi membranes to complete 
this  stage of transport.  To determine if these vesicles are 
functional,  vesicles released from the PYC were separated 
from the donor compartment and incubated with cytosol and 
acceptor membranes in the presence of an ATP-regenerating 
system. Transport was achieved during this incubation and 
membranes within the cells. While previous work has shown 
that the donor PYC used in our assay do not contain the func- 
tional acceptor (Ruohola et al., 1988), it did not preclude the 
possibility that inactive Golgi membranes could be present. 
By Western blot analysis we have shown that Kex2, a protein 
presumed to reside in a late compartment of the Golgi com- 
plex (Julius et al.,  1984; Fuller et al.,  1988), is retained in 
the donor fraction (Groesch and Ferro-Novick, unpublished 
results). Together these findings suggest that inactive Golgi 
membranes are likely to be present in donor cells. The Golgi 
membranes could be inactive either with regard to transport 
or with regard to the enzymes necessary to process the 26- 
kD form of pro-a-factor to a higher molecular mass species. 
These membranes may be inactivated when the cells are per- 
meabilized or during  translocation of prepro-a-factor into 
the donor fraction. 
We have made an  observation which  indicates  that  the 
PYC do contain the modification activities necessary to pro- 
cess 26-kD pro-a-factor to a higher molecular mass form. 
When donor cells, containing the 26-kD and partially glyco- 
sylated forms of pro-a-factor (Fig. 7, lane 1 ), are incubated 
with high concentrations of MnCI2  (5 mM) in the absence 
of cytosol and ATP (Fig. 7, lane 2),  26-kD pro-a-factor is 
processed to the 28-kD species. The presence of high con- 
centrations of divalent cations during this incubation may in- 
duce artifactual fusion between the ER and other membranes 
retained  in the cells,  allowing formation of 28-kD pro-a- 
factor.  This  artifactually  induced  fusion does  not  require 
energy (Fig. 7, lane 5), and as expected, the 28-kD species 
Figure 8. Cytosol is required for late transport  events. The trans- 
port assay was carried out in two steps. In the first step, transport 
vesicles  were  formed  during  an incubation  of donor PYC  with 
cytosol and an ATP-regenerating system. After a 60-min incubation 
at 20°C, the donor PYC were pelleted and the supernatant contain- 
ing vesicles and cytosol was applied to a Sephacryl S-300 column. 
The vesicles  eluted  from the  column  were  concentrated  as de- 
scribed in Materials and Methods. Vesicles (25 #l) were incubated 
with buffer alone (lane 1; b* =  background) or with the accepter 
compartment (lanes 2-6) for 60 rain at 20°C. Incubations with the 
accepter compartment were performed with cytosol (0.8 rag) in the 
presence (lane 2) or absence of ATP (lane 3) or without cytosol in 
the presence (lanes 4 and 5) or absence of ATP (lane 6). Samples 
were  treated  with  Con  A-Sepharose  and  electrophoresed  in  a 
12.5 % SDS-polyacrylamide  gel. The Con A-precipitable material 
was then  reprecipitated  with  anti-outer-chain  antibody  to deter- 
mine the percent of transport. 
The Journal of Cell Biology, Volume 111, 1990  50 Figure 9.  Vesicles formed from a crude membrane fraction can 
complete the transport reaction. The transport assay was executed 
in two steps. Vesicles were formed during a 30-rain incubation of 
donor PYC, crude membranes, and an ATP-regenerating  system at 
20°C. Afterwards, the donor ceils were centrifuged, and the vesi- 
cles remaining in the supernatant were removed (lane 1) and in- 
cubated for an additional 90 min in the presence of a crude mem- 
brane  fraction  containing  functional  Golgi  membranes.  This 
second incubation was performed in the presence (lane 2) or ab- 
sence (lane 3) of ATP or with added cytosol and ATP (lane 4). 
When the assay was performed in one step, a 2 x  concentration of 
crude membranes did not inhibit transport. 
the 26-kD species,  initially contained within carrier vesi- 
cles, was converted to the high molecular mass Golgi form 
(Fig.  8, lane 2). 
We determined whether cytosol is required for the binding 
and fusion of vesicles with the acceptor membrane and sub- 
sequent transport of pro-a-factor to a site of extensive glyco- 
sylation in the Golgi complex. Vesicles formed during an in- 
cubation of donor PYC with cytosol were separated from the 
cytosol by passage through a Sephacryl S-300 column. Cali- 
bration of  the Sephacryl S-300 column demonstrated that the 
vesicles, eluted in the void volume, were cleanly separated 
from two soluble protein markers, BSA (66 kD) and cyto- 
chrome c (12.4 kD). Protease protection experiments indi- 
cated that the column-eluted vesicles were sealed and con- 
tained pro-or-factor (not shown).  Gel-filtered vesicles were 
incubated with various components during a 60-min incuba- 
tion. Conversion of the 26-kD form to the high molecular 
mass species was assessed by precipitation with anti-outer- 
chain antibody and SDS-polyacrylamide gel electrophoresis 
(Figure 8). The control, gel-filtered vesicles incubated with 
buffer alone, did not demonstrate the high molecular mass 
Golgi form of  pro-a-factor. The precipitable counts obtained 
from this sample were subtracted as background (Fig. 8, lane 
b*) from all other samples (Fig. 8, lane 1 ). Column-eluted 
vesicles could go on to complete transport only when they 
were incubated with the acceptor membrane in the presence 
of both ATP and cytosol (Fig.  8, lane 2). Formation of the 
high molecular mass species was dramatically reduced when 
cytosol was eliminated from the assay (Fig. 8, lanes 4 and 
5) or when ATP (lane 3) or both cytosol and ATP (lane 6) 
were eliminated from the assay. The appearance of the high 
molecular mass form of pro-or-factor was dependent on the 
addition  of functional acceptor acceptor membranes  (not 
shown). These findings indicate that vesicles, cytosol, ATP 
and acceptor Golgi membranes are required to complete this 
reaction. 
We have shown that vesicles are released from donor cells 
when they are incubated with a crude membrane fraction in 
the presence of  an ATP-regenerating system. Are the vesicles 
formed in this way also competent to fuse with the Golgi 
complex? To address this question, vesicles were first formed 
during an incubation of donor cells with crude membranes 
(Fig. 9, lane 1). Afterwards, the cells were centrifuged and 
the vesicles were incubated with additional crude membranes 
containing  functional  Golgi  membranes.  This  incubation 
also included cytosol and ATP (Fig. 9, lane 4), ATP alone 
(lane 2), or apyrase to deplete ATP (lane 3). The data in Fig. 
9 indicate that transport was completed only when the sec- 
ond incubation was performed in the presence of cytosol and 
ATP (Fig. 9, lane 4). If the cytosolic fraction was heated to 
95°C for 15 min before use in the assay, it could not support 
conversion of  the 26-kD form of  pro-ix-factor to the high mo- 
lecular mass  species (not shown).  Therefore, crude mem- 
branes can supply the factors required to form vesicles, but 
they cannot provide all the proteins required to transport 
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28kD.---~.. High PIWT 
(vpt I  ) 
Factors + ATP 
Figure 10.  A model for pro-u-factor transport in 
vitro. The transit of pro-tz-factor in vitro is sum- 
marized in this model. Vesicles, containing the 26- 
kD form of pro-a-factor, are released from donor 
PYC when they are incubated with either cytosol 
or a crude membrane fraction in the presence of 
an ATP-regenerating  system. Carder vesicles bind 
to and fuse with the Golgi complex to produce the 
28-kD form of pro-u-factor. This species is then 
converted to a heterogeneous high molecular mass 
species. Conversion of the 26-kD species to the 
high molecular mass (High MWT) Golgi form re- 
quires the presence  of cytosol,  an active Golgi 
fraction, and an ATP-regenerating system. 
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complex. Since the formation and utilization of vesicles re- 
quire different factors, these two processes are likely to be 
biochemicaUy distinct events. 
Discussion 
We have used an in vitro assay to isolate vesicles that are 
functional intermediates in the transport of  proteins from the 
ER to the Golgi complex. This work provides strong support 
for the hypothesis that vesicles are responsible for carrying 
proteins between the ER and Golgi complex (Palade, 1975; 
for a recent review see Lodish, 1988). We have used several 
criteria to establish that the vesicles formed in our assay con- 
stitute a distinct intermediate in ER to Golgi transport. Ki- 
netic studies demonstrate that vesicles are released from per- 
meabilized donor cells before pro-a-factor receives Golgi 
complex-specific modifications. In addition, vesicle forma- 
tion and release requires donor membranes, cytosolic pro- 
teins, and ATE These are requirements anticipated for the 
formation of carrier vesicles since both cytosol and ATP are 
required for the vesicle-mediated movement of  proteins from 
one cisternae of the Golgi complex to another (Balch et al., 
1984; Wattenberg et al., 1986). ATP is also needed for pro- 
tein transport in vivo (Jamieson and Palade,  1968;  Novick 
et al., 1981). The vesicles containing pro-a-factor are a ho- 
mogeneous population that contain no detectable amounts of 
the ER marker protein, HMG1. Since these vesicles contain 
only 26-kD pro-or-factor,  we can conclude that the carrier 
vesicles have not fused with any post-ER compartment re- 
tained within donor cells. Together, these results suggest that 
pro-a-factor is released from the cells in discrete carder 
vesicles derived from donor ER membrane. 
The  kinetics of transport-coupled outer  chain addition 
show an initial lag. This lag is not due to a temporal require- 
ment for the formation and release of vesicles from donor 
cells since vesicle release begins before the lag is completed. 
Consistent with this observation we find that the lag is not 
eliminated when vesicles are added to Golgi membranes at 
the beginning of the time course. The 28-kD species first ap- 
pears during the lag in outer chain addition. This form of 
pro-u-factor is not precipitated with our anti-outer-chain an- 
tibody, possibly because it lacks sufficient carbohydrate de- 
terminants. Therefore, if the 28-kD  species resides in the 
Golgi complex, pro-u-factor may reach the acceptor com- 
partment during the lag. 
Based on previous findings (Ruohola et al.,  1988; Bacon 
et al.,  1989) and results presented here, we have proposed 
a model for pro-a-factor transport in vitro that is diagrammed 
in Figure 10. Vesicle formation and release is dependent on 
the presence of donor membranes, ATE and proteins from 
a yeast lysate. Upon the addition of cytosolic proteins, ATP, 
and a crude membrane fraction containing the functional ac- 
ceptor, these vesicles bind to and fuse with a compartment 
capable of processing 26-kD pro-u-factor to a 28-kD spe- 
cies.  The requirements for the processing of pro-tx-factor 
from the 26- to the 28-kD species suggest that the 28-kD 
form resides in a compartment that is distinct from the vesic- 
ular intermediate. The 28-kD species is then processed to 
higher molecular mass Golgi forms, again suggesting trans- 
port from one compartment to another. In support of this 
model we have shown that 26-kD pro-tx-factor is processed 
to the 28-kD species when vesicles are incubated with low 
concentrations of  cytosolic proteins in the presence of the ac- 
ceptor fraction and ATE If this incubation is performed with 
high concentrations of cytosolic proteins, 26-kD pro-a-fac- 
tor is converted to the high molecular mass form (Bacon, R., 
and S. Ferro-Novick, unpublished results). High concentra- 
tions of cytosol may be required to achieve transport through 
successive cisternae of the Golgi apparatus. The vesicle for- 
mation and releasing factors can be supplied either by cyto- 
sol or a crude membrane fraction; this is in contrast to the 
vesicle attachment and fusion factors that can be supplied 
only by cytosol. Since the activities required to form and uti- 
lize vesicles have different fractionation characteristics, at 
least a subset of these factors is likely to be different. 
Recently, we have shown that a  mutation in  the GTP- 
binding protein, Yptl,  blocks transport in vitro and results 
in the partial accumulation of 28-kD pro-a-factor (Bacon et 
al., 1989).  This and other observations have led to the pro- 
posal that Yptl  is required for conversion of 28-kD pro-et- 
factor to the high molecular mass form and thus may func- 
tion in Golgi membrane transport (Bacon et al., 1989; Segev 
et al., 1988). In addition to this role, genetic studies suggest 
that Yptl could play a role in ER to Golgi membrane trans- 
port (Segev et al., 1988; Schmitt et al., 1988; Bacon et al., 
1989). 
Our in vitro assay offers a powerful advantage for studying 
ER to Golgi protein transport in that we can physically sepa- 
rate transport into two steps. This aspect of the assay has al- 
lowed us to isolate functional intermediate vesicles and will 
facilitate the purification and analysis of this transient com- 
partment. In studying these carder vesicles, we will learn 
more  about  the  mechanism  of  vesicle-mediated  protein 
transport. Toward this end we are currently determining the 
protein composition of the  vesicles.  Antibodies prepared 
against the yeast gene products, implicated in ER to Golgi 
transport, will be useful in this evaluation. Since post-Golgi 
secretory vesicles do not contain a coat (Walworth and No- 
vick, 1987; de Curtis and Simons, 1989) and purified intra- 
Golgi transport vesicles contain a  nonclathrin coat (Mal- 
hotra et al., 1989), it will be interesting to determine if yeast 
ER to Golgi vesicles are coated. Ifa coat exists we can assess 
its composition. This analysis awaits the purification of car- 
rier vesicles. 
At present, we can separate transport from the endoplas- 
mic reticulum through the Golgi complex into two steps, the 
release of vesicles and their utilization. However, the second 
step of our assay is undoubtedly composed of many more 
stages. These stages include the targeting and attachment of 
vesicles to the acceptor and fusion with this membrane to 
permit the mixing of contents. Further refinement of our as- 
say should allow us to dissect the process of ER to Golgi 
transport into these individual events. 
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